Global GenAI study reveals optimism and opportunities for healthcare and life sciences

Marlow, UK – Generative AI (GenAI) is at the forefront of global innovation in both healthcare and life sciences. To better understand how technology is being used, data and AI leader SAS and Coleman Parkes Research conducted a global, cross-industry survey of 237 life sciences and pharma leaders and 240 healthcare leaders who are decision makers […]

Pharma Support Powers Sofinnova Biotech Acceleration Fund

Sofinnova Partners Closes €165M Biotech Acceleration Fund with Strong Pharma Support European life sciences investment firm Sofinnova Partners has announced the final close of its second biotech acceleration fund, raising €165 million and surpassing its original target. The fund, Sofinnova Biovelocita II, now holds the title as the largest pan-European initiative of its kind, with […]

Shilpa Biologicals Pvt Ltd signs strategic development partnership with mAbTree Biologics AG for a novel immuno-oncology asset

Basel Switzerland, and Karnataka India:  mAbTree Biologics AG has signed an exclusive co-development and commercialization partnership with Shilpa Biologicals Pvt Ltd. (a fully owned subsidiary of Shilpa Medicare Limited) for its novel biologic asset [a checkpoint inhibitor] for immuno-oncological applications. Under the terms of the strategic agreement, Shilpa Biologicals will support both development – including clinical studies – as […]

Sirio Launches Global Research Institute for Longevity Studies [SIA]

Research Institute to advance nutraceutical product development across four core research areas SIRIO Pharma (SIRIO) – the global nutraceutical contract development and manufacturing organization (CDMO) – announces the launch of the Sirio Institute for Anti-Ageing (SIA) at the 2025 Boao Health Food Science Conference and Expo. The Institute aims to advance anti-ageing science and accelerate the development and commercialization of […]

Shilpa Launches ‘hybrid CDMO’ at DCAT

Shilpa Medicare launches its new full service ‘hybrid’ CDMO at DCAT 2025. The newly formed CDMO will see Shilpa serve both small and large molecules customers as well as peptides – with oncology a particular therapeutic specialism. In addition to offering comprehensive discovery, clinical, and commercial outsourcing services, Shilpa’s ‘hybrid CDMO model’ also includes commercially ready […]

Операция «Дәрмек»: на медработников завели уголовные дела

Смотрите в этом выпуске: — Больше сотни медработников наказали за нарушения при работе с наркотическими средствами. Возбуждено восемь уголовных дел. МВД подвело итоги операции «Дәрмек».— Антисанитария и смрад: подпольный мясной цех выявили в Актюбинской области;— Нарушил ПДД и проигнорировал полицейских. Водителя большегруза оштрафовали и поместили в изолятор на трое суток. Читайте нас в Telegram! Теги #24 kz […]

фармацевтика

Фармацевтика – Новости Казахстана и мира

Regenerative Medicine Makeover Via Artificial Intelligence

While the regenerative medicine spectrum continues its upward trend, artificial intelligence incorporation happens to be playing a role that’s especially transformative in the pharmaceutical sector. The fact is that AI-driven drug discovery can go on to evaluate chemical compounds that are in the millions in a fraction of the time it would usually take by […]

Artificial Intelligence – Giving Clinical Trial A Facelift

Across the past so many years, there have been pharmaceutical companies that have been integrating artificial intelligence steadily into many elements of clinical development. The effect that artificial intelligence has today is indeed being felt right from the bench to the clinic and even beyond. As per the survey conducted by the Tufts Centre for […]

BioPharma Drug Development Workflow and Techniques

Drug development is a long and complex process that starts with discovery and, if successful, ends with government approval for marketing. Each step in the drug development process, outlined below, has specific goals with the aim of down-selecting appropriate hits and candidates to an approved drug substance. Here, we discuss the relevant objectives and techniques […]